+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Our laboratory and clinical experience with the antifungal agent miconazole

Our laboratory and clinical experience with the antifungal agent miconazole

Medicina Interna 33(6): 465-474

Sensitivity to miconazole was tested for 184 isolates of Candida (114), Geotrichum (18), Aspergillus (50) and Mucoraceae (2) from patients with deep or superficial mycoses. Of the isolates, 32 were sensitive to 0.1-1 mu g/ml, 66 to 5-10 mu g/ml. The remainder (including both mucoraceous isolates) were only slightly sensitive or resistant.

(PDF emailed within 1 workday: $29.90)

Accession: 001105999

Download citation: RISBibTeXText

Related references

Laboratory and clinical experience with the anti fungal agent miconazole. Revista de Medicina Interna Neurologie Psihiatrie Neurochirurgie Dermato-Venerologie Serie Medicina Interna 33(6): 465-474, 1981

Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials. Future Microbiology 3(3): 265-269, 2008

Our laboratory and clinical experience with miconazole. Revista de Medicina Interna, Neurologe, Psihiatrie, Neurochirurgie, Dermato-Venerologie. Medicina Interna 33(6): 465-474, 1981

Our experiences with the antifungal agent Miconazole. Ceskoslovenska Dermatologie 49(4): 248-250, 1974

Miconazole nitrate: a new antifungal agent. Veterinary Medicine, Small Animal Clinician 70(12): 1438-1440, 1975

Miconazole: An effective antifungal agent for plant tissue culture. Plant Cell Tissue & Organ Culture 32(3): 293-301, 1993

A new antifungal agent, miconazole nitrate, in the treatment of superficial mycoses of the glabrous skin. Ibid (289): 753-754, 1974

The use of the antifungal agent miconazole as an inhibitor of Blastocystis hominis growth in Entamoeba histolytica/E-dispar cultures. Revista do Instituto de Medicina Tropical de Sao Paulo 49(3): 201-202, 2007

In vivo and in vitro effects of the antifungal agent miconazole on estrogen biosynthesis in human breast cancer. European Journal of Cancer & Clinical Oncology 25(10): 1493-1498, 1989

Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent. PharmacoTherapy 35(11): 1037-1051, 2015

5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. Annals of Internal Medicine 76(1): 15-22, 1972

Comparison of the in vitro antifungal activities of clotrimazole, miconazole, Econazole and exalamide against clinical isolates of dermatophytes. Nihon Hifuka Gakkai Zasshi. Japanese Journal of Dermatology 92(6): 671-675, 1982

Clinical trial of a new antimycotic agent, miconazole. Ibid (289): 729-733, 1974

In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses. Japanese Journal of Antibiotics 44(5): 571-579, 1991